United States · Bill · S
S. 3250 (116th)
DHS Opioid Detection Resilience Act of 2020
Introduced
4 February 2020
Last action
—
Status
Read twice and referred to the Committee on Homeland Security and Governmental Affairs.
Sponsors
—
Subjects
Discovery layer
Source updated
14 January 2025
Summary
DHS Opioid Detection Resilience Act of 2020 This bill establishes new requirements related to the detection of illicit narcotics at ports of entry. Specifically, U.S. Customs and Border Protection (CBP) must implement a strategy to ensure chemical screening devices are able to identify narcotics at purity levels equal to or less than 10%, or provide an alternate method for identifying narcotics at lower purity levels. The CBP must also test new chemical screening devices at various purity levels before it commits to their acquisition. Additionally, the Department of Homeland Security must implement a plan for the long-term development of a centralized spectral database for chemical screening devices.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in Senate (text)
Introduced in Senate (text)
Introduced in Senate · EN · 4 February 2020
Introduced in Senate (PDF)
Introduced in Senate · EN · 4 February 2020
Introduced in Senate
summary · EN · 4 February 2020
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/116th-congress/senate-bill/3250
- Open data entity: https://api.congress.gov/v3/bill/116/s/3250